Bizotic Commercial Gets ₹6.72 Cr from Promoters' 5th Warrant Tranche

TEXTILE
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Bizotic Commercial Gets ₹6.72 Cr from Promoters' 5th Warrant Tranche
Overview

Bizotic Commercial Limited's board has approved receiving ₹6.72 crore as the fifth payment tranche for convertible warrants from its promoter group. This capital infusion, part of a preferential issue, will support the company's working capital and operations.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Bizotic Commercial Receives ₹6.72 Crore 5th Tranche Warrant Funds from Promoters

Bizotic Commercial Limited announced on March 25, 2026, that it received ₹6.72 crore as the fifth tranche of payment for its convertible warrants. The funds came from promoter group entities, with Ms. Sangita Annmol Aggarwala contributing ₹5.12 crore and M/s. Bizotic Nexus Private Limited adding ₹1.60 crore.

Board Approves Fifth Tranche

The company's Board of Directors met on March 25, 2026, to approve receiving the fifth installment for convertible warrants. This payment totaled ₹6.72 crore from promoter group entities. Ms. Sangita Annmol Aggarwala provided ₹5.12 crore, while M/s. Bizotic Nexus Private Limited contributed ₹1.60 crore. The warrants were issued at ₹290 each, consisting of a ₹280 premium and a ₹10 face value, under a preferential allotment for the 'Promoter and Promoter Group Category' as per SEBI regulations.

Promoter Commitment and Working Capital Boost

This continued capital infusion from promoters demonstrates their ongoing financial commitment to Bizotic Commercial. The funds are expected to strengthen the company's working capital, supporting its daily operations. This financial backing is important as the company manages its business activities and its strategic transition.

Background on Warrant Issuances

Bizotic Commercial designs and markets men's apparel, using third-party contractors. The company has a history of issuing convertible warrants to its promoter group on a preferential basis since late 2025. Multiple payment tranches have been approved and received. Previously, the second tranche of ₹6.98 crore was received on March 2, 2026, and the third tranche of ₹4.71 crore on March 17, 2026. In February 2026, the board approved allotting 12.58 lakh warrants to promoters for a potential ₹364.82 crore. The company has also previously adjusted its warrant issue goals to focus solely on working capital needs.

Impact of the Funds

The receipt of these funds will improve liquidity for working capital needs and reinforces the financial backing from the promoter group. It allows for the continued execution of the company's capital-raising strategy through warrants, supporting ongoing operations and potential business transitions.

Risks to Watch

Investors should watch for potential shareholder dilution if warrants are fully converted. Key risks include the company's ability to achieve profitable growth in its core garment business and the success of its strategic transition into Pharma API manufacturing. The company also relies on promoter funding for operational stability.

Peer Comparison

Bizotic Commercial operates in the competitive branded apparel sector, alongside peers like Kewal Kiran Clothing Ltd (KKCL), which also focuses on menswear. For context, KKCL reported 17.3% revenue growth and 11.8% profit growth in FY24. Larger players such as Trent Ltd and Avenue Supermarts Ltd operate on a significantly larger scale, indicating the market reach and financial strength needed to lead the retail sector.

Financial Performance Snapshot

Bizotic Commercial reported total revenue of ₹112.39 crore for FY2025, a 47.84% year-on-year increase. Net profit for FY2025 was ₹4.29 crore, up 38.99% from the prior fiscal year. As of March 2026, the company's market capitalization was around ₹900 crore.

What to Track Next

Investors will monitor future warrant tranches and their amounts, along with the total number of warrants converted and their impact on paid-up capital and shareholding. Company announcements on fund utilization and working capital management progress will be key. Updates on the strategic transition to Pharma API manufacturing, its financial implications, and the core garment business's organic growth will also be closely watched.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.